SATELLOS Co-Founder and Chief Scientific Officer Dr. Michael Rudnicki Officially Recognized as a Fellow of the Royal Society
TORONTO, June 22, 2022 – Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Corporation”), a
TORONTO, June 22, 2022 – Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Corporation”), a
TORONTO, June 17, 2022 – Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a
SATELLOS BIOSCIENCE INC. TO PRESENT AT BIO INTERNATIONAL CONVENTION 2022 - Dr. Ryan Mitchell, PhD
Presentation on Tuesday, June 7th, at 10:00 AM PT Westlake Village, California--(Newsfile Corp. - June
Satellos Bioscience Inc. Announces First Quarter Financial Results and Operational Highlights TORONTO, May 31, 2022
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO,
SATELLOS BIOSCIENCE INC. INVITED TO PRESENT AT THE 2022 BLOOM BURTON & CO. HEALTHCARE INVESTOR
SATELLOS BIOSCIENCE INC. TO PRESENT GAME CHANGING SCIENCE AT UPCOMING EUROPEAN MOLECULAR BIOLOGY ORGANIZATION WORKSHOP Ryan
SATELLOS BIOSCIENCE INC.’s CSO TO PRESENT GAME CHANGING SCIENCE DURING MARCH 30th DRUG DISCOVERY NEWS WEBINAR
Toronto, March 15, 2022 - Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Company”), a